Coil occlusion combined with sclerotherapy versus N-butyl-2 cyanoacrylate (NBCA) embolization in patients with pelvic venous disorders (PeVD): A single center retrospective study.
Hossam Zaghloul, Mahmoud Nasser, Hisham Abd El-Mawgoud, Baker Ghoneim, Mohammed Ali
{"title":"Coil occlusion combined with sclerotherapy versus N-butyl-2 cyanoacrylate (NBCA) embolization in patients with pelvic venous disorders (PeVD): A single center retrospective study.","authors":"Hossam Zaghloul, Mahmoud Nasser, Hisham Abd El-Mawgoud, Baker Ghoneim, Mohammed Ali","doi":"10.1016/j.jvsv.2025.102241","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Pelvic Venous Disorder (PeVD) is increasingly diagnosed with different modalities of treatment.</p><p><strong>Patients and methods: </strong>This is a retrospective study in which we compared using metallic coil combined with sclerosant foam N-Butyl-2 Cyanoacrylate (NBCA) in females with PeVD in terms of clinical and technical success as well as safety. Adult patients with symptoms suggestive of primary PEVD and confirmed with Doppler US and /Or venography were eligible for the study. Secondary PeVD and lost Follow up were excluded.</p><p><strong>Results: </strong>this study included 167 patients who were treated with coil and sclerotherapy (n = 87; Group I) or NBCA (n = 80; Group II) embolization. Immediate postoperative veins' closure was achieved in all patients in the two groups. At the 6-month follow-up, there was a statistically significantly higher occlusion rate in Group I (100% compared to 93.8% in Group II, p = 0.018) with five new cases of recanalization. The 6-month VAS score was lower in Group I (median of 1 and mean of 1.14 ± 0.904) than Group II (median of 2 and mean of 1.7 ± 1.32), with a statistically significant difference (p = 0.005).</p><p><strong>Conclusion: </strong>The study emphasizes the potential advantages of the sclerosant foam and metallic coil combination in achieving favorable outcomes for patients with PeVD.</p>","PeriodicalId":17537,"journal":{"name":"Journal of vascular surgery. Venous and lymphatic disorders","volume":" ","pages":"102241"},"PeriodicalIF":2.8000,"publicationDate":"2025-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of vascular surgery. Venous and lymphatic disorders","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.jvsv.2025.102241","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Pelvic Venous Disorder (PeVD) is increasingly diagnosed with different modalities of treatment.
Patients and methods: This is a retrospective study in which we compared using metallic coil combined with sclerosant foam N-Butyl-2 Cyanoacrylate (NBCA) in females with PeVD in terms of clinical and technical success as well as safety. Adult patients with symptoms suggestive of primary PEVD and confirmed with Doppler US and /Or venography were eligible for the study. Secondary PeVD and lost Follow up were excluded.
Results: this study included 167 patients who were treated with coil and sclerotherapy (n = 87; Group I) or NBCA (n = 80; Group II) embolization. Immediate postoperative veins' closure was achieved in all patients in the two groups. At the 6-month follow-up, there was a statistically significantly higher occlusion rate in Group I (100% compared to 93.8% in Group II, p = 0.018) with five new cases of recanalization. The 6-month VAS score was lower in Group I (median of 1 and mean of 1.14 ± 0.904) than Group II (median of 2 and mean of 1.7 ± 1.32), with a statistically significant difference (p = 0.005).
Conclusion: The study emphasizes the potential advantages of the sclerosant foam and metallic coil combination in achieving favorable outcomes for patients with PeVD.
期刊介绍:
Journal of Vascular Surgery: Venous and Lymphatic Disorders is one of a series of specialist journals launched by the Journal of Vascular Surgery. It aims to be the premier international Journal of medical, endovascular and surgical management of venous and lymphatic disorders. It publishes high quality clinical, research, case reports, techniques, and practice manuscripts related to all aspects of venous and lymphatic disorders, including malformations and wound care, with an emphasis on the practicing clinician. The journal seeks to provide novel and timely information to vascular surgeons, interventionalists, phlebologists, wound care specialists, and allied health professionals who treat patients presenting with vascular and lymphatic disorders. As the official publication of The Society for Vascular Surgery and the American Venous Forum, the Journal will publish, after peer review, selected papers presented at the annual meeting of these organizations and affiliated vascular societies, as well as original articles from members and non-members.